Navigation Links
Leading for Growth in the New Economic Reality Includes Vision and Innovation
Date:6/16/2009

DuPont CEO Ellen Kullman outlines leading in a dynamic and unpredictable world at Wharton Leadership Conference.

Philadelphia, PA (Vocus) June 16, 2009 -- As the global recession has changed the landscape of many markets DuPont serves, the company is well-positioned to deliver dynamic innovations to meet the evolving markets demand because “change is in our DNA,” said DuPont CEO Ellen J. Kullman at the 13th Annual Wharton Leadership Conference here today.

“There is no playbook for what the world is experiencing right now, but several leadership principles have surfaced in our experience at DuPont and seem particularly appropriate to the dynamic and uncertain conditions we currently face today,” Kullman said. “At DuPont, change is in our DNA. The four leadership principles that have emerged are: focus on what you can control, adopt a new trajectory, communicate and maintain pride around your mission.”

During its 207 years, DuPont has evolved through three transformations, emerging stronger each time as the company continues to innovate through economic downturns, Kullman said. She noted that nylon was discovered during the Great Depression. “None of that happened by accident. It took leaders who had a vision and were absolutely determined to not waste a good crisis,” Kullman said.

Today, as a market-driven science company, DuPont continues its legacy of delivering innovation during challenging times. Kullman said the company’s research and development efforts – including more than three-quarters of its R&D budget -- are focused on three major global “megatrends:” the need for increasing food productivity, decreasing dependence on fossil fuels and protecting lives. DuPont delivered more than $10 billion in sales from new products that are less than five years old in 2008. In the first quarter of 2009, the company commercialized more than 500 new products – nearly double compared to the first quarter of 2008.

“At DuPont, we have often been successful by stepping out of our comfort zone and adopting a new trajectory,” Kullman said. “We are not afraid to aggressively pursue fundamental change, whether it is new business models, new scientific or technological platforms or other basic change.”

Several specific examples highlighted by Kullman included innovative business models successfully executed in the company’s Safety Resources and Applied BioSciences businesses; new market-driven technologies for Kevlar® and Nomex® high performance materials; and a strong focus on tailoring innovations to meet specific needs in emerging economies, like China and India.

“In the new economic reality, DuPont continues to deliver market-back science to make the world a better and safer place,” Kullman said. “We must be prepared not for the world the way it was before the recession, but prepare to succeed in the very different world that we’ll encounter when the recovery eventually comes.”

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries and regions, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

###

Read the full story at http://www.prweb.com/releases/Dupon_Wharton/Leadership_Conference/prweb2540534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
4. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
7. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leading for Growth in the New Economic Reality Includes Vision and Innovation
(Date:2/9/2016)... of Prussia, PA (PRWEB) , ... February 09, 2016 , ... ... Business Development, Europe. Based in Paris, he will focus on acquiring new accounts ... are being met. , “Fred brings to our European clients more ...
(Date:2/9/2016)... Feb. 9, 2016  DNAtrix, a clinical ... cancer, announced that its lead product, DNX-2401, ... as an orphan medicinal product for the ... of glioma, strikes approximately 25,000 people a ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> ...
(Date:2/9/2016)... 2016 BERG, a biopharmaceutical company uncovering ... has announced the appointment of Jason Haddock ... Officer. Haddock brings to BERG over 20 years ... in senior financial functions at pharmaceutical companies, as ... management. Niven R. Narain , ...
(Date:2/8/2016)... , Feb. 8, 2016  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced that it ... agreement with Hercules Technology Growth Capital, Inc. and ... million in financing. --> ... $25 million of financing under the loan and ...
Breaking Biology Technology:
(Date:2/3/2016)... -- Vigilant Solutions announces today that the ... solved two recent hit-and-run cases with the ... Solutions. Brian Wenberg explains, "I was ... out of a convenience store and witnessed an elderly male back out ... his vehicle and leaving the scene.  In his statement ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):